Clsi M22a3 Pdf Link May 2026

The CLSI M22-A3 standard outlines quality control requirements for commercially prepared microbiological culture media, reducing the need for user testing on "proven reliability" media while establishing an acceptable failure rate of ≤0.5%. While applicable internationally, US laboratories now primarily follow Individualized Quality Control Plans (IQCP) under CLIA regulations rather than strictly adhering to M22-A3, which was updated to include 27 additional exempt media types. Purchase the document directly at

https://clsi.org/standard/m22-a3/

The M22-A3 standard has undergone several revisions, with the most recent version being published in 2020. Some key changes include: clsi m22a3 pdf link

What is CLSI M22-A3?

Understanding CLSI M22-A3: Quality Control for Commercial Microbiology Kits

were added to the "exempt" list, meaning users often do not need to perform routine quality control on these if purchased from a manufacturer following these standards. Failure Rate Adjustments : The acceptable failure rate cutoff was expanded from 0.3% to 0.5% Defined Responsibilities The impact of M22-A3 extends beyond simple cost-saving

1. Blood Culture Collection: The guidelines provide recommendations for the collection of blood cultures, including the selection of patients, choice of blood culture bottles, and techniques for blood sampling.
2. Transport and Receipt: The guidelines outline the requirements for transporting blood cultures to the laboratory and the procedures for receiving and processing them.
3. Processing and Testing: The guidelines provide recommendations for processing and testing blood cultures, including incubation, subculturing, and identification of microorganisms.
4. Quality Control and Quality Assurance: The guidelines emphasize the importance of quality control and quality assurance in blood culture testing, including the use of quality control samples and ongoing monitoring of test performance.

The impact of M22-A3 extends beyond simple cost-saving measures; it enhances the overall quality of diagnostic microbiology. By focusing laboratory efforts on "non-exempt" media—those with higher failure rates or more complex nutritional requirements, such as chocolate agar or selective media for fastidious organisms—pathologists and technicians can dedicate more attention to the variables that actually influence patient outcomes. This risk-based approach aligns with modern Quality Management System (QMS) principles, ensuring that QC efforts are proportionate to the likelihood of media failure. including the selection of patients